Display options
Share it on

Theranostics. 2022 Jan 01;12(1):379-395. doi: 10.7150/thno.67034. eCollection 2022.

Smad3 deficiency improves islet-based therapy for diabetes and diabetic kidney injury by promoting β cell proliferation .

Theranostics

Hong-Lian Wang, Biao Wei, Hui-Jun He, Xiao-Ru Huang, Jing-Yi Sheng, Xiao-Cui Chen, Li Wang, Rui-Zhi Tan, Jian-Chun Li, Jian Liu, Si-Jin Yang, Ronald Cw Ma, Hui-Yao Lan

Affiliations

  1. Research Center for Integrated Medicine and Department of Nephrology, Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, China.
  2. Department of Medicine and Therapeutics, and Li Ka Shing Institute of Health Sciences, the Chinese University of Hong Kong, Hong Kong, 999077, China.
  3. Guangdong-Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, China.
  4. State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Sciences & Medical Engineering, Southeast University, Nanjing, China.
  5. Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524001, China.
  6. National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, China.
  7. CUHK-Guangdong Provincial People's Hospital Joint Research Laboratory on Immunological and Genetic Kidney Diseases, the Chinese University of Hong Kong, Hong Kong, 999077, China.

PMID: 34987651 PMCID: PMC8690916 DOI: 10.7150/thno.67034

[No abstract available.]

© The author(s).

Keywords: E2F3; Smad3; cell cycle; diabetes; islet transplantation

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

References

  1. Mol Carcinog. 2009 Mar;48(3):181-186 - PubMed
  2. Endocrinology. 2016 Apr;157(4):1348-56 - PubMed
  3. Nat Rev Endocrinol. 2015 Apr;11(4):201-12 - PubMed
  4. Endocrine. 2021 Jun;72(3):660-671 - PubMed
  5. Cold Spring Harb Perspect Biol. 2017 Apr 3;9(4): - PubMed
  6. Diabetologia. 2014 Jan;57(1):157-66 - PubMed
  7. Nat Protoc. 2009;4(11):1649-52 - PubMed
  8. Diabetes. 2014 Jan;63(1):224-36 - PubMed
  9. EMBO J. 1999 Mar 1;18(5):1280-91 - PubMed
  10. Diabetes. 2016 May;65(5):1208-18 - PubMed
  11. Int J Biol Sci. 2011;7(7):1056-67 - PubMed
  12. J Biol Eng. 2017 Jul 3;11:21 - PubMed
  13. Metabolism. 2020 Feb;103:154013 - PubMed
  14. Genes Dev. 1998 Aug 1;12(15):2245-62 - PubMed
  15. Nat Rev Endocrinol. 2017 May;13(5):268-277 - PubMed
  16. Transplantation. 2009 Dec 15;88(11):1286-93 - PubMed
  17. J Vis Exp. 2007;(9):404 - PubMed
  18. Theranostics. 2021 Jan 1;11(6):2845-2859 - PubMed
  19. J Vis Exp. 2011 Apr 13;(50): - PubMed
  20. Cell Cycle. 2013 Aug 15;12(16):2691-702 - PubMed
  21. Front Physiol. 2015 Mar 19;6:82 - PubMed
  22. Cell Metab. 2019 Mar 5;29(3):638-652.e5 - PubMed
  23. Nat Rev Neurosci. 2001 May;2(5):333-42 - PubMed

Publication Types